KDCXF yields 125.00% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 10
Combined, KDCXF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KDCXF + MRK for your $10,000?
Kudelski SA develops and delivers a range of digital security solutions for digital television and interactive applications in Switzerland, the United States, France, the Netherlands, and internationally. It operates through four segments: Digital TV, Cybersecurity, Internet of Things (IoT), and Public Access. The Digital TV segment offers integrated solutions, including open conditional access solutions, which allow TV operators and content providers to operate various value-added pay-TV services on a secure platform, and middleware software solutions for set-top boxes and other consumer devices; and intellectual property consulting services. The Cybersecurity segment provides cybersecurity solutions to enterprises and public sector institutions, which include consulting, technology and resale services, managed security and custom developed proprietary products, and threat intelligence solutions that help organizations to build and run security programs. The IoT segment offers device security through identity authentication and firmware protection; data security to ensure the confidentiality, integrity, and authenticity of sensitive data; and access management and active security protections to enable secure processing, local decision making, and threat detection and response. The Public Access segment provides access control systems and ticketing services for ski lifts, car parks, stadiums, concert halls, and other events. The company also offers watermarking solutions; smartcards and digital TV sales and support services; research and development services; finance services; and research and development digital broadcasting solutions, as well as operates a travel agency. Kudelski SA was founded in 1951 and is headquartered in Cheseaux-sur-Lausanne, Switzerland.
Full KDCXF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.